Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.07% | $120.89M | €334.77B | 38.25% | 76 Outperform | |
| AstraZeneca | 1.43% | $83.60M | £210.71B | 35.34% | 76 Outperform | |
| Nestlé SA | 1.34% | $77.93M | CHF201.86B | 12.62% | 71 Outperform | |
| HSBC Holdings | 1.29% | $75.29M | £187.79B | 46.16% | 79 Outperform | |
| Roche Holding AG | 1.28% | $74.50M | CHF230.07B | 40.88% | 73 Outperform | |
| SAP SE | 1.27% | $74.35M | €241.59B | -5.92% | 66 Neutral | |
| Novartis AG | 1.26% | $73.73M | CHF201.32B | 12.01% | 80 Outperform | |
| Toyota Motor | 1.18% | $68.97M | ¥40.65T | 10.93% | 81 Outperform | |
| Shell (UK) | 1.13% | $66.14M | £164.04B | 9.52% | 77 Outperform | |
| Siemens | 0.98% | $56.97M | €174.65B | 24.00% | 74 Outperform |